Sensus Healthcare Q2 revenue up 358% YoY to $5.4M; net loss narrows to $0.3M

Sensus Healthcare, Inc.

2022-Q2 EPS reported -$0.08 revenue$8,492,000

Revenue $5.4M, up 358% YoY and 77% sequentially; shipped 17 systems including 7 SRT-100 Vision.
Net loss improved to $(0.3)M ($0.02 loss per share) from $(2.6)M loss in Q2 2020; Adjusted EBITDA $(0.1)M vs $(2.3)M.
Cash $15.2M at June 30, 2021; worldwide installed base of SRT systems reached 515.
CMS increased reimbursement for SRT effective Jan 2021; new leasing options; expanding international in China and India.
Management cautiously optimistic for sequential growth; on track to profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.